(PDF) Neoantigens Retention in Patient Derived Xenograft

Neoantigens Retention in Patient Derived Xenograft Models Mediates Autologous T Cells Activation in Ovarian Cancer

OncoImmunology - United States

doi 10.1080/2162402x.2019.1586042

Full Text

Abstract

Available in full text

Categories

Date

March 30, 2019

Authors

Muzamil Yaqub Want

Satoko Matsueda

Sebastiano Battaglia

Publisher

Informa UK Limited

Related search

Targeting HER2 in Patient-Derived Xenograft Ovarian Cancer Models Sensitizes Tumors to Chemotherapy

Molecular Oncology

Cancer Research

Molecular Medicine

English

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer According to Tumorigenicity in Patient-Derived Xenograft Models

Cancer Research and Treatment

Cancer Research

English

Bioengineered miRNA-1291 Prodrug Therapy in Pancreatic Cancer Cells and Patient-Derived Xenograft Mouse Models

Cancer Research

English

Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research

Cancer and Metastasis Reviews

Cancer Research

English

Establishment of Lung Cancer Patient-Derived Xenograft Models and Primary Cell Lines for Lung Cancer Study

Journal of Translational Medicine

Molecular Biology

English

Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine

Frontiers in Oncology

Cancer Research

English

Lymphoma Transformation of Tumor Infiltrating Lymphocytes Observed in Testicular Patient‑derived Xenograft Models

Oncology Reports

Cancer Research

English

Patient-Derived Cancer Xenograft Xebrafish Model (PDXZ) and Personalized Medicine

Proceedings for Annual Meeting of The Japanese Pharmacological Society

English

Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma

Journal of the American College of Surgeons

English